Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of <i>Acinetobacter baumannii</i>.

Moussa, Samir H; Shapiro, Adam B; McLeod, Sarah M; Iyer, Ramkumar; Carter, Nicole M; Tsai, Yu-Kuo; Siu, L Kristopher; Miller, Alita A

Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii.

Moussa, Samir H; Shapiro, Adam B; McLeod, Sarah M; Iyer, Ramkumar; Carter, Nicole M; Tsai, Yu-Kuo; Siu, L Kristopher; Miller, Alita A.

Affiliation

Moussa SH; Innoviva Specialty Therapeutics Inc., an affiliate of Entasis Therapeutics Inc. , Waltham, Massachusetts, USA.
Shapiro AB; Innoviva Specialty Therapeutics Inc., an affiliate of Entasis Therapeutics Inc. , Waltham, Massachusetts, USA.
McLeod SM; Innoviva Specialty Therapeutics Inc., an affiliate of Entasis Therapeutics Inc. , Waltham, Massachusetts, USA.
Iyer R; Innoviva Specialty Therapeutics Inc., an affiliate of Entasis Therapeutics Inc. , Waltham, Massachusetts, USA.
Carter NM; Innoviva Specialty Therapeutics Inc., an affiliate of Entasis Therapeutics Inc. , Waltham, Massachusetts, USA.
Tsai Y-K; Kemyth Biotech Co., Ltd. , Taipei City, Taiwan.
Siu LK; Kemyth Biotech Co., Ltd. , Taipei City, Taiwan.
Miller AA; Innoviva Specialty Therapeutics Inc., an affiliate of Entasis Therapeutics Inc. , Waltham, Massachusetts, USA.

Antimicrob Agents Chemother ; 67(11): e0066523, 2023 11 15.

Article de En | MEDLINE | ID: mdl-37843305

Sujet(s)
Mots clés

Acinetobacter; ETX2514; durlobactam; resistance; sulbactam; surveillance studies

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sulbactam / Acinetobacter baumannii Langue: En Journal: Antimicrob Agents Chemother Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google